APDN Awarded Extension of Health Services Contract with CUNY
August 9th, 2022
All Categories
APDN in the News
Corporate/Financial News
Investors
Large-Scale DNA Production
Linear DNA
Press Release
Uncategorized
Vaccines
Category: Press Release
APDN Receives ~$3.6 Million in Net Proceeds from Warrant Exercise
August 9th, 2022
APDN to Host Conference Call and Webcast Discussing FQ3’22 Results
August 8th, 2022
APDN Announces Closing of $12M Upsized Public Offering
August 8th, 2022
APDN Announces Pricing of $12M Upsized Public Offering
August 4th, 2022
APDN Initiates Validation of PCR-based Monkeypox Diagnostic Test
August 2nd, 2022
LineaRx, EvviVax Publish Additional Positive Animal Proof-of-Concept Data
July 25th, 2022
Applied DNA Biotherapeutics Subsidiary LineaRx to Present Data Showcasing Advantages of its Enzymatically Produced LinearDNA as Substitute for Plasmid DNA in IVT mRNA Production
July 22nd, 2022
LinearDNA: Alternative to Plasmid DNA for Therapeutic Applications
June 29th, 2022
